Evidence map›Paper›PMID 36079732›Full record

Trial reportNutrients2022

Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study.

Alessandro Maselli Del Giudice, Ignazio La Mantia, Francesco Barbara, Silvana Ciccarone, Maria Sterpeta Ragno, Valentina de Robertis, Francesco Cariti, Michele Barbara, Luca D'Ascanio, Arianna Di Stadio

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Alessandro Maselli Del GiudiceDepartment Otorhinolaryngology, Hospital of Barletta, 76121 Barletta (BT), Italy.
Ignazio La MantiaDepartment GF Ingrassia, University of Catania, 95123 Catania, Italy.
Francesco BarbaraDepartment Otorhinolaryngology, University Hospital of Bari, 70126 Bari, Italy.ORCID 0000-0003-2187-595X
Silvana CiccaroneDepartment Otorhinolaryngology, Hospital of Barletta, 76121 Barletta (BT), Italy.
Maria Sterpeta RagnoDepartment Otorhinolaryngology, Hospital of Barletta, 76121 Barletta (BT), Italy.
Valentina de RobertisDepartment Otorhinolaryngology, Hospital of Barletta, 76121 Barletta (BT), Italy.
Francesco CaritiDepartment Otorhinolaryngology, Hospital of Barletta, 76121 Barletta (BT), Italy.
Michele BarbaraDepartment Otorhinolaryngology, Hospital of Barletta, 76121 Barletta (BT), Italy.
Luca D'AscanioDepartment Otorhinolaryngology, Azienda Ospeliera Riunita Marche Nord (AORMN), 61032 Fano (PU), Italy.ORCID 0000-0002-5351-326X
Arianna Di StadioDepartment GF Ingrassia, University of Catania, 95123 Catania, Italy.ORCID 0000-0001-5510-3814
University of Catania · ITOspedali Riuniti Marche Nord · ITUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elderly people are at high risk of suffering from infection and being affected by severe forms of disease because their immunosystem suffers from aging. The alteration of normal immune functions causes the increase of pro-inflammatory cytokines which can expose these people to increased risk of developing pathologies as cancer, diabetes, and/or arthritis. Some supplements could be helpful for restoring normal immune functions. We conducted a case-control study to evaluate the efficacy of a supplement containing Sambucus nigra, zinc, tyndallized Lactobacillus acidophilus (HA122), arabinogalactans, vitamin D, vitamin E, and vitamin C to improve the inflammatory levels (IL-6 and CRP) and to modulate the lymphocytes growth. Additionally, we analyzed wellness by self-questionnaire. This study had two control group: a young group and an elderly one. Our study showed that treating elderly patients with the supplement for 30 days improved IL-6, CRP, and lymphocytes levels; the result was independent from the dosage of the supplements used. Elderly patients, despite the improvement, were not able to reach the same conditions of young patients; however, most of the patients (>70%) claimed to “feel better” after the use of the supplement. The use of this supplement should be considered at a low dosage for a prolonged period to reduce inflammation and modulate immune senescence in patients over 60 years old.

Indexed as

Dietary SupplementsInterleukin-6AgedCase-Control StudiesHumansInflammationMiddle AgedVitamin DVitaminsInterleukin-6Vitamin DVitaminsagingimmuno-senescenceinflammatory cytokinesnutraceuticalsoral supplementvitamin Cvitamin Dzinc

Identifiers

PMID36079732
PMCPMC9459752
OpenAlexW4293221263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.